Thanks for osting this @tigertiger2 initially I had a quick look and didn't go any further. But had some time tonight and wondered if there might be something in the White Paper that would distinguish Bactisure Wound Lavage and Xperience and there was. See the first dot point below (after the first paragraph).So there it is in writing, you have to rinse BWL out, so, at face value, it's a different product to Xperience. I can now understand why NXS might fight this. Sceptics please don't bother I understand the other arguments.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $40.96M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.5¢ | $1.622K | 11.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 798101 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 529904 | 11 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| NXS (ASX) Chart |